ALNY News Alert Alnylam Pharmaceuticals (ALNY) 95.54 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 10:45 AM

Alnylam Pharmaceuticals (ALNY) 95.54 $ALNY

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ALNY: 95.54 (+1.67), BRP: 24.17 (+0.01), ADHD: 6.92 (+0.73), ALSN: 31.88 (+0.24), ACGL: 59.95 (+0.36)

Alnylam Pharma ups revenues 122% in Q4
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:21AM CST

ALNY: 95.54 (+1.67)

Incyte Posts Wider-than-Expected Q4 Loss; Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:20AM CST
Incyte Corporation (INCY) reported a fourth-quarter 2014 loss of 22 cents per share, wider than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 15 cents per share.
ALNY: 95.54 (+1.67), INCY: 75.94 (+0.28), LLY: 70.56 (+0.03), NVS: 102.20 (-0.17)

Alnylam Reports Narrower Loss in Q4, Focuses on Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 7:19AM CST
Alnylam's (ALNY) fourth-quarter 2014 loss of 28 cents per share was much narrower than the Zacks Consensus Estimate of a loss of 66 cents and the year-ago loss of 51 cents per share.
MON: 124.77 (+2.00), ALNY: 95.54 (+1.67), MDCO: 29.79 (+0.91), OPHT: 51.11 (+0.12)

Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 10:14PM CST

ALNY: 95.54 (+1.67)

Loaded-Up Alnylam Pharmaceuticals, Inc. Progresses Its Pipeline
Brian Orelli, The Motley Fool - Motley Fool - Thu Feb 12, 6:53PM CST
Alnylam Pharmaceuticals is going to need plenty of cash to get to its goal of having three marketed products and 10 clinical programs in 2020. Fortunately, that's not a major problem at this point. Alnylam ended last year with $882 million in cash...
ALNY: 95.54 (+1.67), SNY: 49.42 (+0.82)

Alnylam reports 4Q loss
Automated Insights - Thu Feb 12, 5:01PM CST
CAMBRIDGE, Mass. (AP) _ Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a loss of $21.4 million in its fourth quarter.
ALNY: 95.54 (+1.67)

Alnylam Pharmaceuticals (ALNY) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 12, 3:25PM CST

ALNY: 95.54 (+1.67)

Alnylam Pharmaceuticals beats by $0.32, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 3:03PM CST

ALNY: 95.54 (+1.67)

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Recent Period Progress
Business Wire - Thu Feb 12, 3:00PM CST
--- Presented Positive Data from Multiple Clinical Programs, Including Initial Evidence of Potential Disease Modifying Effects with Patisiran and ALN-AT3 -
ALNY: 95.54 (+1.67)

Hospira Beats on Q4 Earnings, Set to Be Acquired by Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 9:28AM CST
Hospira's fourth-quarter 2014 adjusted earnings of 53 cents per share easily beat the Zacks Consensus Estimate of 41 cents.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), PFE: 34.64 (-0.23), HSP: 87.35 (unch)

A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals
PR Newswire - Thu Feb 12, 7:30AM CST
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.34 (unch), AFAM: 30.88 (+0.37), ALNY: 95.54 (+1.67), AMAG: 41.49 (+0.23), ALQA: 6.14 (+0.09)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:35PM CST

TNGO: 12.11 (+0.42), ELLI: 50.06 (+2.67), WWWW: 16.59 (+0.64), CYBR: 52.52 (+6.83), JCOM: 65.83 (+6.29), DLR: 68.65 (-2.07), SFLY: 44.86 (-2.13), KRFT: 64.42 (-1.75), NR: 9.85 (+1.07), CGNX: 41.82 (+0.95), MTSN: 4.04 (+0.19), WAGE: 62.17 (+3.72), RGC: 23.23 (+1.35), VCRA: 9.86 (+0.68), ALNY: 95.54 (+1.67), AIZ: 61.44 (-4.98), AEL: 29.15 (+0.66), EGN: 69.90 (+3.59), INT: 53.72 (+2.28), LBTYA: 52.49 (+2.70), LOGM: 52.22 (+4.17), CUZ: 11.26 (+0.25), PRO: 23.01 (-0.85), ZNGA: 2.24 (-0.42), BCOR: 14.20 (-0.45), GRPN: 7.97 (+0.51), KING: 16.70 (+1.96), SSNC: 63.38 (+1.40), PFIE: 2.60 (-0.06), KN: 18.59 (-3.05), COLM: 51.50 (+7.91), RSG: 39.34 (-1.67), SSTK: 56.49 (-2.75), TCO: 74.67 (-5.21), INWK: 6.29 (+0.69), MGI: 8.61 (-0.83), DVA: 73.10 (-3.29), IRWD: 15.15 (-0.85), BYD: 14.36 (-0.23), QLIK: 31.17 (+1.09), MOBL: 9.53 (-0.21), RBCN: 4.53 (-0.13), AIG: 53.96 (+1.51), CBS: 59.83 (+2.06)

Celgene Up on Abraxane Getting Positive Recommendation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:59PM CST
Celgene Corporation (CELG) was up 1.7% after the company announced that Abraxane has received a positive recommendation from the Scottish Medicines Consortium.
ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20), LLY: 70.56 (+0.03), CELG: 115.88 (+0.16)

Synthetic Biologics Unveils Phase Ib Safety Data on SYN-004 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 12:30PM CST
Synthetic Biologics, Inc. (SYN) announced positive top-line results from phase Ib study on SYN-004.
SYN: 2.13 (+0.18), BMRN: 100.76 (+1.98), ALNY: 95.54 (+1.67)

Zoetis Beats on Q4 Earnings, Provides In-Line 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:56AM CST
Zoetis' fourth-quarter 2014 adjusted earnings of 40 cents per share were ahead of the Zacks Consensus Estimate.
ZTS: 45.46 (-0.33), ABT: 46.09 (+0.87), ALNY: 95.54 (+1.67), ACHN: 10.89 (-0.20)

Orexigen Gives Positive Updates on its Weight Loss Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 3:30PM CST
Orexigen Therapeutics (OREX) announced encouraging updates on its weight loss drug, Mysimba
BIIB: 391.66 (-0.45), OREX: 5.55 (+0.10), ALNY: 95.54 (+1.67)

Regeneron Beats on Q4 Earnings Driven by Eylea Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 8:28AM CST
Regeneron Pharmaceuticals (REGN) reported fourth-quarter 2014 adjusted earnings (including stock-based compensation expense) of $2.16 per share.
ALNY: 95.54 (+1.67), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)

Will Kforce (KFRC) Earnings Surprise on Improving Business? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 2:19PM CST
Staffing company, Kforce Inc. (KFRC) is scheduled to report its fourth-quarter 2014 results on Feb 10 after the market closes.
CENX: 23.10 (-0.17), ALNY: 95.54 (+1.67), KFRC: 23.24 (+0.26), ACGL: 59.95 (+0.36)

Will Republic Services (RSG) Surprise on Q4 Earnings This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 2:12PM CST
Republic Services (RSG) is scheduled to report its fourth-quarter 2014 results on Feb 12 after the closing bell.
CENX: 23.10 (-0.17), ALNY: 95.54 (+1.67), RSG: 39.34 (-1.67), ACGL: 59.95 (+0.36)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Gourmia Introduces Ceramic-Coated Air Fryer at Costco

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Oracle Announces AI-Driven QuickStart Platform Launch

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Vayo Debuts as Booking Holdings Eyes $100M Investment

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

AI-Powered Travel Transformation in Norway Revealed

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...